A comparison between the effects of two liposome-encapsulated bevacizumab formulations on ocular neovascularization inhibition
M Malakouti–Nejad, D Monti, S Burgalassi… - Colloids and Surfaces B …, 2024 - Elsevier
Abstract Bevacizumab (BVZ), an anti-VEGF antibody, has demonstrated reliable outcomes
in the treatment of irritating ocular neovascularization. Frequent intravitreal injections are …
in the treatment of irritating ocular neovascularization. Frequent intravitreal injections are …